OBJECTIVE: To determine whether therapeutic education added to conventional drug therapy reduced disability and pain in patients with early rheumatoid arthritis (RA). METHODS:Fourty-three patients with RA, 29F/14 M, were included in a randomized, controlled trial and assigned to a control group receiving conventional pharmacological treatment only (n=21), or an intervention group receiving therapeutic education added to conventional pharmacological treatment (n=22). The main outcome variable was self-reported disability on the Stanford health assessment questionnaire (HAQ). RESULTS: At 18 months, patients in the intervention group had less disability (HAQ), pain intensity, number of tender and swollen joints, and patient's and physician's global assessments (p=0.003, 0.031, 0.003, 0.001, 0.014, and 0.004, respectively) compared with baseline, and improvements in disability and number of tender and swollen joints (p=0.024, 0.040, and 0.003, respectively), compared with controls. CONCLUSIONS: Patients receiving pharmacological treatment and therapeutic education had a better evolution than those receiving only pharmacological treatment.
RCT Entities:
OBJECTIVE: To determine whether therapeutic education added to conventional drug therapy reduced disability and pain in patients with early rheumatoid arthritis (RA). METHODS: Fourty-three patients with RA, 29F/14 M, were included in a randomized, controlled trial and assigned to a control group receiving conventional pharmacological treatment only (n=21), or an intervention group receiving therapeutic education added to conventional pharmacological treatment (n=22). The main outcome variable was self-reported disability on the Stanford health assessment questionnaire (HAQ). RESULTS: At 18 months, patients in the intervention group had less disability (HAQ), pain intensity, number of tender and swollen joints, and patient's and physician's global assessments (p=0.003, 0.031, 0.003, 0.001, 0.014, and 0.004, respectively) compared with baseline, and improvements in disability and number of tender and swollen joints (p=0.024, 0.040, and 0.003, respectively), compared with controls. CONCLUSIONS:Patients receiving pharmacological treatment and therapeutic education had a better evolution than those receiving only pharmacological treatment.
Authors: C Scholten; T Brodowicz; W Graninger; I Gardavsky; K Pils; B Pesau; E Eggl-Tyl; A Wanivenhaus; C C Zielinski Journal: Arch Phys Med Rehabil Date: 1999-10 Impact factor: 3.966
Authors: Y Lindroth; M Brattström; I Bellman; G Ekestaf; Y Olofsson; B Strömbeck; B Stenshed; I Wikström; J A Nilsson; F A Wollheim Journal: Arthritis Care Res Date: 1997-10
Authors: J Patermann; I Ehlebracht-König; G Lind-Albrecht; E Genth; A Reusch; R Küffner; U Müller-Ladner; J Braun Journal: Z Rheumatol Date: 2016-03 Impact factor: 1.372
Authors: In Du Jeong; Moo In Park; Sung Eun Kim; Beom Jin Kim; Sang Wook Kim; Jie-Hyun Kim; Hye Young Sung; Tae-Hoon Oh; Yeon Soo Kim Journal: J Neurogastroenterol Motil Date: 2017-07-30 Impact factor: 4.924
Authors: Omalkhaire M Alshaikh; Issa M Alkhonain; Muath S Anazi; Albaraa A Alahmari; Feras O Alsulami; Abdulrhman A Alsharqi Journal: Cureus Date: 2021-11-14